Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
DIDIY DiDi Global Inc
QLGN Qualigen Therapeutics Inc
JOFF JOFF Fintech Acquisition Corp
IR Ingersoll Rand Inc
TGT Target Corp
CCLP CSI Compressco LP
BIOT Biotech Acquisition Co
XNXNX Nuveen New York Select Tax Free Income Portfolio
DHHC DiamondHead Holdings Corp
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is for the treatment of psychosis in Alzheimer's disease (AD), which is the prevalent subtype of dementia-related psychosis (DRP). KarXT is a combination of xanomeline and trospium. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms associated with schizophrenia and dementia-related psychosis (DRP). Its muscarinic receptors serve a number of physiological roles, including in cognitive, behavioral, sensory, motor and autonomic processes.

Postmarket

Last Trade
Delayed
$200.01
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$200.01
Day's Change
-0.78 (-0.39%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
204.40
Day's Low
199.21
Volume
(Above Average)
Volume:
356,348

10-day average volume:
312,745
356,348
  • Prev Close
    200.79
  • Today's Open
    201.12
  • Day's Range
    199.21-204.40
  • Avg Vol (10-day)
    312.7K
  • Last (time)
    4:00p ET 12/07/22
  • Last (size)
    13
  • 52-Wk Range
    92.26 - 278.25
    LowHigh
  • (05/12/22 - 08/12/22)
    28.12%
  • 77.4%
  • Market Cap
    6.9B
  • Shares Outstanding
    34.4M
  • -7.45
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 98.37
  • (% of float 11/15/22)
    5.34

Latest News

December 06, 2022
6:30 am ET
BusinessWire
December 04, 2022
9:54 pm ET
Newsfile
November 04, 2022
12:15 pm ET
Zacks
November 03, 2022
6:30 am ET
BusinessWire
November 01, 2022
6:30 am ET
BusinessWire
October 11, 2022
9:00 am ET
BusinessWire
October 06, 2022
4:30 pm ET
BusinessWire
September 22, 2022
10:31 am ET
Globe Newswire
September 13, 2022
6:33 am ET
MarketWatch
August 09, 2022
7:59 am ET
MarketWatch
7:43 am ET
MarketWatch
6:20 am ET
MarketWatch
August 08, 2022
7:56 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.